ライフサイエンスコーパス: Env protein

1 IV-1 particles bearing the SERINC5-resistant Env protein.

2 ved Gag and the cytoplasmic tail (CT) of the Env protein.

3 l proteins and a singly spliced mRNA encodes Env protein.

4 ous neutralization determinants on the HIV-1 Env protein.

5 d on the surface of the gp120 subunit of the Env protein.

6 icular stomatitis virus (VSV) expressing HIV Env protein.

7 ch region in the surface (SU) subunit of the Env protein.

8 binant expressing a secreted form of the HIV Env protein.

9 levels of antibody responses against the HIV Env protein.

10 boosted (week 8) with the DNA or recombinant Env protein.

11 he induction of XC cell syncytia by the R(+) Env protein.

12 lowed by two doses of NYVAC vector and gp120 Env protein.

13 usion-inducing conformational changes in the Env protein.

14 diversity and poor immunogenicity of the HIV Env protein.

15 rize the phenotypic features of the M-tropic Env protein.

16 ts a need for broad antibodies targeting the Env protein.

17 with about 500 glycoforms characterized per Env protein.

18 rains LAI and NL4.3 lack wild-type levels of Env proteins.

19 HERV-K(HML-2)] and the expression of Gag and Env proteins.

20 ents of HTLV-3 using independently expressed Env proteins.

21 uld confer this property on two heterologous Env proteins.

22 tness similar to those carrying the mothers' Env proteins.

23 tance mutations into phenotypically distinct Env proteins.

24 e leukemia virus (MLV), bearing heterologous Env proteins.

25 rotocol with their homologous vaccine native Env proteins.

26 endent virus, and with subgroups A or B ASLV Env proteins.

27 ls that were transformed by the JSRV or ENTV Env proteins.

28 ke particles (VLPs), both FV and HBV require Env proteins.

29 m by comparing tier 1 NL Env with tier 3 AD8 Env proteins.

30 ably, this entry block is dependent on viral Env proteins.

31 r the 17b antibody than are IFITM3-resistant Env proteins.

32 h MA facilitates the virion incorporation of Env proteins.

33 uences largely encoded intact and functional Env proteins.

34 ning technique of obtaining novel retargeted Env proteins.

35 properties have been described for subtype C Env proteins.

36 ) that are buried in the parental, unadapted Env proteins.

37 ons in the HR1 region of the viral envelope (Env) protein.

38 e V3 glycan supersite on the HIV-1 envelope (Env) protein.

39 he sequence of the capsid (CA) and envelope (Env) proteins.

40 the amphotropic murine leukemia virus 4070A Env protein (2).

41 -displayed human antibody library; these two Env proteins (89.6 and IIIB gp140s), and one additional

42 ccine will include a recombinant form of the Env protein, a trimer located on the virion surface.

43 Here, we investigated whether ENV protein affects oligodendroglial differentiation.

44 bsets prior to immunization with recombinant Env protein affects the vaccine-induced Ab response in m

45 of the IgG binding response than those with Env protein alone.

46 The viral envelope (Env) protein alone can transform cultured cells, and we

47 e show that expression of the JSRV envelope (Env) protein alone in lungs of mice, by using a replicat

48 IV vaccines have included purified envelope (Env) protein among the boosting components of the regime

49 anding of the humoral responses to the HIV-1 Env protein and provide insights regarding the most rele

50 (MD) simulations of a model glycosylated HIV Env protein and related systems.

51 ximately normal amounts of Gag, Gag-Pol, and Env proteins and genomic viral RNA (vRNA), but several m

52 ortant influences on the quality of trimeric Env proteins and hence their suitability as vaccine comp

53 tivated in cells transformed by JSRV or ENTV Env proteins and in cells transformed by the proteins wi

54 reflect different interactions between their Env proteins and molecules on CD4(+) and CD8(+) T cells

55 V Env proteins or an interaction between the Env proteins and PI3K in the transformed cells.

56 human immunodeficiency virus type 1 (HIV-1) Env proteins and possess broad neutralizing activities.

57 enome, in addition to the structural Gag and Env proteins and retroviral enzymes, carries a region at

58 protein alters the conformation of the HIV-1 Env proteins and that this action is correlated with SER

59 l conformational heterogeneity of some HIV-1 Env proteins and, by extrapolation, also vaccine immunog

60 led vaccine targets on the virus's envelope (Env) protein and are themselves promising immunotherapie

61 obe interactions between the viral envelope (Env) protein and CXCR4 and to identify pathways by which

62 ns within the V3 loop of the viral envelope (Env) protein and was modulated by additional mutations i

63 ined viral sequences in their DNA, expressed Env protein, and showed retroviral particles by electron

64 ular protein, Zfp111, that binds to the JSRV Env protein, and this binding plays a role in Env transf

65 lowed by two doses of NYVAC vector and gp120 Env protein; and T4 was two doses of DNA vector and gp12

66 ssing the human immunodeficiency virus (HIV) Env protein are nonpathogenic in mice, even when given b

67 However, the precise mechanism by which Env proteins are acquired during virus assembly has yet

68 IFITM3-sensitive Env proteins are also more susceptible to neutralization

69 These data suggest that VIR165-dependent Env proteins are kinetically trapped in the unliganded s

70 To increase yield and simplify purification, Env proteins are often made in truncated, soluble forms.

71 to SERINC5, whereas the majority of tier 2/3 Env proteins are resistant to SERINC5, when viruses are

72 Notably, tier 1 HIV-1 Env proteins are sensitive to SERINC5, whereas the major

73 ubstantial subset of potential epitopes when Env proteins are used as immunogens.

74 r the further design and production of HIV-1 Env proteins as the critical components of HIV-1 vaccine

75 The HIV-1 Env proteins assemble as trimers, and incorporation of t

76 f trimer spokes have been observed to impair Env protein assembly into virus particles, and several o

77 to HIV-1 gp120, suppress interactions of the Env protein at host cell receptor binding sites, inhibit

78 recombinant expressing the membrane-anchored Env protein at producing CD8 T cells and antibody respon

79 nstrated to contain high levels of the viral env proteins, averaged 70-79 trimers per virion in tomog

80 Therefore, Env protein-based vaccination strategies can protect aga

81 Chimeric Env proteins between JSRV and the unrelated murine retro

82 yl lipid A and QS-21 (MPLA+QS-21)-adjuvanted Env protein boost (D(IP-10) P(ALFQ)) in macaques, we obs

83 ncept that a distally related retroviral SIV Env protein boost can increase pre-existing NAb response

84 v and monovalent gag) followed by a 5-valent Env protein boost for seronegative adults was previously

85 These data demonstrate that the adjuvanted Env protein boost is critical for protecting against hig

86 through a DNA prime, recombinant oligomeric Env protein boost regimen.

87 vs) DNA prime, followed by a SIVmac239 gp140 Env protein boost that aimed to focus the immune respons

88 prime-recombinant NYVAC (rNYVAC) vector and Env protein boost vaccination strategy.

89 of the alphavirus replicon vector prime plus Env protein boost vaccine approach for the induction of

90 Here we show that Ad prime, Env protein boost vaccines protect against neutralizatio

91 at received the intramuscular VRP prime plus Env protein boost were completely protected.

92 (gp120) followed by a co-delivered NYVAC and Env protein boost.

93 Recombinant Gag and Env protein boosting elicited rapid and strong recall re

94 Of note, Env protein boosting induced serum-neutralizing antibodi

95 rated that were predominantly detected after Env protein boosting.

96 e characteristics and immunogenicity of this Env protein, both alone and mixed together with a clade

97 that the FIV tetherin antagonist is also its Env protein, but the mechanism is distinctive.

98 g antibodies (nAbs) to some cloned SIVsmE660 Env proteins, but antibodies able to neutralize the chal

99 e to restore BST-2 antagonism to an inactive Env protein by a single-amino-acid change.

100 he murine leukemia virus (MLV) transmembrane Env protein by the viral protease in MLV Env-pseudotyped

101 man immunoglobulin G that reacted with HIV-1 Env proteins by enzyme-linked immunosorbent assay and ne

102 Here we show that JSRV and ENTV Env proteins can also transform Madin-Darby canine kidne

103 Env proteins can better mediate entry into cells after c

104 These results show that the JSRV and ENTV Env proteins can transform epithelial cells besides BEAS

105 s so they may not accurately represent HIV-1 Env proteins circulating in humans, potentially limiting

106 Thus, an HIV-1 subtype C Env protein (CO6980v0c22) from an infected person in the

107 diated at least in part by the YFV envelope (env) protein coding RNA.

108 r proteins may influence surface exposure of Env protein complexes in virus-infected cells, assisting

109 Co-administration of gp120 Env protein components with DNA or NYVAC vectors during

110 n overlapping peptide pools from three HIV-1 Env proteins, CON6, MN (subtype B), and Chn19 (subtype C

111 region of Env, suggesting subtle changes in Env protein conformation.

112 NLHX; however, all of the PFI-insusceptible Env proteins conserved the sequence of a critical enfuvi

113 us type 1) uses its trimeric gp160 envelope (Env) protein consisting of non-covalently associated gp1

114 Moreover, some soluble recombinant Env proteins contain aberrant disulfide bonds that are n

115 unodeficiency virus type 1 (HIV-1) envelope (Env) protein contains numerous N-linked carbohydrates th

116 Among HIV-1 gene products, the envelope (Env) protein contains variable as well as conserved regi

117 versification, even though antibodies to the Env protein could be detected much earlier.

118 fected by ENTV vectors, even though the ENTV Env protein could bind well to human Hyal2 expressed on

119 humoral and cellular immune responses to the Env protein could reveal potential determinants of vacci

120 possibility that these endogenous retroviral Env proteins could directly influence HIV-1 replication.

121 virions by virtue of an interaction with the Env protein cytoplasmic tails (CTs).

122 For both X4-tropic and R5-tropic Env proteins, DeltaCT induced faster fusion kinetics tha

123 the CD4-binding site of the HIV-1 envelope (Env) protein (denoted VRC01) was modified by site-direct

124 irus envelope (Env) have been conducted with Env proteins derived from clade B viruses isolated durin

125 en soluble gp140 and virion-associated gp160 Env proteins derived from SF162 may be the basis for the

126 tion sensitivities of HIV-1 pseudotyped with Env proteins derived from two prototypic clade B primary

127 ay measurable binding to a recombinant gp140 Env protein (derived from the dual-tropic 89.6 virus), w

128 protein in the boosting phase along with the Env protein did not contribute further to the preservati

129 The results demonstrated that ancestral Env proteins did not impart broad levels of protection a

130 rsions of CZA97.012 and 92UG037.8 oligomeric Env proteins do not resemble the trimeric Env glycoprote

131 These findings suggest that the Env protein domains responsible for spongiogenesis repre

132 0 and boosted with MPLA-plus-alum-adjuvanted Env protein (DP(ALFA)) The D(IP-10) P(ALFQ) vaccine regi

133 candidate HIV-1 vaccine vectors and purified Env proteins elicited potent and durable humoral immune

134 Seven new epitopes mapped to the viral Env protein, emphasizing Env as a major target of CTLs.

135 possessed long env open reading frames, the Env proteins encoded by these loci were nonfunctional ac

136 ntry, and entry is mediated by the envelope (Env) proteins encoded by these viruses.

137 However, mosaic Env proteins expressed as trimers have not been previous

138 We found HERV-K env protein expression in 88% of BC (n = 119) but not in

139 and T4 was two doses of DNA vector and gp120 Env protein followed by two doses of NYVAC vector and gp

140 ine leukemia virus retroviral Envelope (FeLV Env) protein for productive infection of feline AH927 ce

141 The Env protein from gibbon ape leukemia virus (GaLV) has be

142 ne (expressing clade B Gag, Pol, and Nef and Env proteins from clades A, B, and C) was administered a

143 (VSV), but viral entry is mediated by HIV-1 Env proteins from diverse HIV-1 strains.

144 he context of seven different parental HIV-1 Env proteins from diverse subtypes.

145 nsmitting HIV-1C-infected women against four Env proteins from heterologous viruses.

146 ggest that a multicomponent vaccine encoding Env proteins from multiple clades of HIV-1 can generate

147 large numbers of SHIV constructs expressing Env proteins from newly transmitted HIV-1 strains.

148 The entry tropism of HIV-1 Env proteins from virus isolated from the blood and geni

149 We have analyzed HIV-1 envelope (Env) proteins from 66 individuals infected with the majo

150 n for their ability to incorporate envelope (Env) proteins from other retroviral strains and genera,

151 odies, soluble HIV-1 envelope glycoproteins (Envs proteins) from two isolates complexed with two-doma

152 However, recent structural studies of HIV-1 Env proteins, generation of novel bNAbs, maturation of t

153 The HIV envelope (Env) protein gp120 is protected from antibody recognitio

154 ng to the HR-1 region of the viral envelope (Env) protein gp41 subunit.

155 Early administration of gp120 Env protein (groups T2 and T4) was associated with a sub

156 ults indicate that the R peptide of the MuLV Env protein has a sequence-dependent inhibitory effect o

157 mmunodeficiency virus type 1 (HIV-1) surface Env protein has been implicated in the development of HI

158 mates (NHPs) were boosted with various SOSIP Env proteins; however, significant neutralization was no

159 10-fold more Ag-specific GC Tfh cells in HIV Env protein-immunized macaques (BG505 SOSIP).

160 Whether non-clade B Env protein immunogens will elicit antibodies with epito

161 cles in general and perhaps also for soluble Env proteins.IMPORTANCE Recombinant trimeric SOSIP prote

162 ble of lysing target cells expressing HERV-K env protein in BC patients but not in normal female cont

163 s were primed with VRP and then boosted with Env protein in MF59 adjuvant, or they were given VRP int

164 62) gp140DeltaV2 envelope (Env) and trimeric Env protein in MF59 adjuvant.

165 s Env (Con-S), and a global trivalent mosaic Env protein in rhesus macaques.

166 domain (CTD) of murine leukemia virus (MuLV) Env protein in viral fusion was indicated by the potent

167 Here, we examined the role of the Env protein in virus-induced mammary tumorigenesis in vi

168 d characterized viruses pseudotyped with the Env proteins in a single-round drug sensitivity assay.

169 Three Env proteins in a trimer contact each other at their api

170 the virus ensures the production of Gag and Env proteins in an appropriate ratio remains unknown.

171 Expression of the JSRV envelope (Env) protein in mouse airway epithelial cells induces si

172 between T cell-tropic and macrophage-tropic Env proteins, including functional differences with host

173 y, entry kinetics, intrinsic infectivity, or Env protein incorporation.

174 The R(+) Env protein induced syncytia in XC cells expressing a mu

175 rAd41 expressing HIV envelope (Env) protein induced cellular immune responses comparabl

176 litates the incorporation of HIV-1 envelope (Env) proteins into virions by virtue of an interaction w

177 he human immunodeficiency virus type 1 gp120 Env protein is a key domain in Env due to its role in in

178 Env glycoprotein components.IMPORTANCE HIV-1 Env protein is a major target for the development of an

179 as the R peptide, the fusion activity of the Env protein is activated.

180 Although the GALV Env protein is commonly used to make high-titer pseudoty

181 We demonstrated that the ENV protein is present in close proximity to TLR4-expres

182 herefore, analysis of glycans on recombinant Env proteins is highly significant.

183 at the more promiscuous use of CCR5 by these Env proteins is selected against at the level of virus t

184 The gp120 subunit of the HIV-1 envelope (Env) protein is heavily glycosylated at approximately 25

185 human immunodeficiency virus (HIV) envelope (Env) protein is incorporated into HIV virions or virus-l

186 f the murine leukemia virus (MuLV) envelope (Env) protein is known to play an important role in regul

187 of these simple retroviruses, the envelope (Env) protein is the active oncogene.

188 We analyzed the properties of multiple Env proteins isolated from five patients who experienced

189 The Env proteins isolated from the genital tract of subject

190 ported on a panel of HIV-1 clade B envelope (Env) proteins isolated from a patient treated with the C

191 However, a mutant Env protein lacking this region remained associated with

192 In addition, KoRV env protein lacks an intact CETTG motif that we have ide

193 essing JSRV Env caused a marked reduction in Env protein levels, indicating that human Hyal2 suppress

194 The trimeric Moloney murine leukemia virus Env protein matures by two proteolytic cleavages.

195 These results suggest that some engineered Env proteins may more efficiently direct responses towar

196 Env proteins mediate virus entry via extensive conformat

197 g antibodies directed at the HIV-1 envelope (Env) protein might block outgrowth of some reservoir vir

198 gths of the individual Env-receptor bonds of Env proteins obtained from a HIV-1 infected patient prio

199 ion of immune escape variants.IMPORTANCE The Env protein of HIV is highly glycosylated, and the sites

200 The Env protein of murine leukemia virus matures by two clea

201 r their ability to inhibit entry mediated by Env proteins of delta- and gammaretroviruses.

202 at Hyal2, can suppress transformation by the Env proteins of JSRV and ENTV.

203 We tested the Env proteins of JSRV and MMTV, as well as human endogeno

204 ically evaluated the differences between the Env proteins of simian immunodeficiency virus/simian HIV

205 characteristics of the binding of V3 MAbs to Env proteins of the subtype B virus JR-FL and the subtyp

206 The envelope (Env) protein of HERV-K18 encodes a superantigen that str

207 The envelope (Env) protein of HIV is the major viral determinant that

208 LaSota/gp160, expressing the gp160 envelope (Env) protein of HIV-1 from an added gene.

209 The envelope (Env) protein of human immunodeficiency virus type 2 (HIV

210 his includes understanding how the Envelope (Env) protein of these virions interacts with the T-cell

211 t peptide in the Vr1 region of the envelope (Env) proteins of feline leukemia virus (FeLV) subgroups

212 However, both membrane-bound Env proteins on the surface of intact viruses remained c

213 The engineering of soluble Env proteins on which the PG9 and PG16 epitopes are opti

214 aced by that of the wild-type or mutant MuLV Env protein or in which the cytoplasmic tail sequence of

215 y of SU for appropriate configuration of the Env protein or independent activation by SU of a signali

216 s received active immunizations with subunit Env protein or modified vaccinia Ankara (MVA)-vectored E

217 ect tyrosine phosphorylation of JSRV or ENTV Env proteins or an interaction between the Env proteins

218 gether, these studies indicate that the MMTV Env protein participates in mammary epithelial cell tran

219 erate in culture; express Tax, Rex, Gag, and Env proteins persistently; and transmit HTLV-1 to naive

220 agsiekte sheep retrovirus Env transgene, the Env protein physically associates with HYAL2.

221 method could influence the proportion of an Env protein population that contained aberrant disulfide

222 The gp145 Env protein presented in this study forms physical trime

223 eneral, the alanine mutations did not affect Env protein production or its localization to the plasma

224 fficiency and fusion competency of the viral Env proteins relate to infection during this transition

225 erior envelope glycoprotein (Env), nonnative Env protein released from cells, and the glycan shieldin

226 For HIV-2, the envelope (Env) protein replaces the role of Vpu.

227 ous data have shown that the HIV-1 Envelope (Env) protein requires an interaction with MA for assembl

228 trimer complex showed additional contacts to Env protein residues by SF12 compared with VRC-PG05, the

229 and that at least two of the most expressed Env proteins retain their ability to make a protein.

230 e always replaced, both coding for envelope (Env) protein segments: the N terminus of the surface sub

231 unodeficiency virus type 1 (HIV-1) envelope (Env) protein serves as a barrier to antibody-mediated ne

232 accines and therapeutics targeting the HIV-1 Env protein should consider virus variation within indiv

233 Moreover, this engineered mini-Env protein should facilitate three-dimensional structur

234 ans when using the SHIV/macaque model, HIV-1 Env proteins should be identified that use mCD4 as a fun

235 ion to the V5 variable loop of the envelope (Env) protein showed that viruses bearing HI insertions r

236 croscopy performed on the BG505 SOSIP mutant Env proteins shows rearrangements in the gp120 topologic

237 ncreased breadth of recognition of different Env proteins, suggesting anti-V regions 1 and 2 Abs may

238 iable domain (V2) of the HIV gp120 envelope (Env) protein, suggesting this region as a target for vac

239 l of both domains is required to enhance HIV Env protein surface stability.

240 revealed that glycans masked most of the SIV Env protein surface, with ITS90 targeting a glycan hole,

241 lowed by two doses of NYVAC vector and gp120 Env protein; T2 comprised four doses of NYVAC vector and

242 mprised four doses of NYVAC vector and gp120 Env protein; T3 was two doses of DNA vector followed by

243 In Gag, Pol, and Env proteins, TAN1 differed from west-central African SI

244 fication of a novel nuclear form of the JSRV Env protein that binds Zfp111.

245 HIV-1 B/C recombinant, native-like trimeric Env protein that is highly resistant to CD4-induced conf

246 Here, we identified several soluble gp140 Env proteins that are recognized by PG9 and PG16, and we

247 trimer adds to the repertoire of native-like Env proteins that are suitable for immunogenicity and st

248 The identification of soluble Env proteins that express the PG9 and PG16 epitopes and

249 bored genetically and phenotypically diverse Env proteins that used CCR5 and/or CXCR4 to elicit membr

250 ing on D17 canine cells yielded D17-specific Env proteins that used the FeLV-C receptor.

251 ansmitted to infants IP, but not IU, encoded Env proteins that were shorter and had fewer putative N-

252 We created several chimeric Env proteins that, unlike the parental Env, do not trans

253 unodeficiency virus type-1 (HIV-1) envelope (Env) proteins that mediate membrane fusion represent a m

254 perties of the viral envelope glycoproteins (Env proteins) that influence the ability of HIV-1 to ind

255 T cell responses engendered was against the Env protein, the Mamu-A*02-restricted epitope, Env(788-7

256 nclude that for both X4-tropic and R5-tropic Env proteins, the CT facilitates conformational changes

257 tions are commonly observed in ENF-resistant Env proteins, though their role remains unclear.

258 ate the cell surface expression of envelope (Env) proteins through peptide sequences located in the c

259 roglial precursor cells were stimulated with ENV protein to determine the effects of this ligand/rece

260 ogeneity in the susceptibility of individual Env proteins to coreceptor inhibitors.

261 of anti-Env Abs can be improved by coupling Env proteins to costimulatory molecules such as a prolif

262 MAbs, C108g did not block binding of soluble Env proteins to either the CD4 or the CCR5 receptor, but

263 ining synthetic Galcer and recombinant HIV-1 Env proteins to identify antibodies that would block the

264 which multivalent binding of trimeric HIV-1 Env proteins to MA trimers contributes to the process of

265 t that multivalent binding of trimeric HIV-1 Env proteins to MA trimers contributes to the process of

266 membrane (PM) assembly sites where envelope (Env) protein trimers are incorporated into virus particl

267 TANCE The mechanism by which HIV-1 envelope (Env) protein trimers assemble into virus particles is po

268 egimens that delayed administration of gp120 Env protein until the 3-month vaccination (groups T1 and

269 These Env proteins used an unidentified non-FeLV receptor for

270 The HIV envelope (Env) protein uses a dense coat of glycans to mask conser

271 eceptor responses to SHIV(AD8) infection and Env protein vaccination with eight different adjuvants.

272 This study describes a candidate HIV-1 Env protein vaccine whose sequence has been designed by

273 both alone and mixed together with a clade C Env protein vaccine, are described.

274 idual represents a source of closely related Env protein variants that can be used to explore various

275 Thus, the BG505 Env protein warrants further investigation as an HIV vac

276 ch the cytoplasmic tail sequence of the MuLV Env protein was added to the HA cytoplasmic domain.

277 lated on serine residues, but the native BLV Env protein was not phosphorylated either in transfected

278 Env protein was undetectable in dead mutants, while RC a

279 t to the plasma membrane of selected deleted Env proteins was confirmed by confocal immunofluorescenc

280 among targeting peptides of library-selected Env proteins was greater than that found in parental FeL

281 he NXT/S N-linked glycosylation motif of the Env protein, we created 27 mutants lacking 1 to 5 of 14

282 In summary, using patient-derived Env proteins, we found that ENF failure was associated w

283 xplore whether Tier-2 nAbs can be induced by Env proteins, we immunized conventional mice with solubl

284 st, viruses pseudotyped with subtype A and C Env proteins were able to use the recently described alt

285 Mother and infant Env proteins were also similar in sensitivity to soluble

286 For these studies, libraries of Env proteins were cloned from infected subjects and scre

287 The nucleotide sequences of the Env proteins were then compared for pairs of neutralizat

288 simian immunodeficiency virus (SIV) Gag and Env proteins were used to vaccinate rhesus macaques with

289 ave created a RV containing a chimeric HIV-1 Env protein, which contains introduced cysteine residues

290 We postulated that co-administration of Env protein with either a DNA or NYVAC vector during pri

291 ergent in sequence, the two viruses share an Env protein with similarly curtailed VRA and VRB regions

292 protein, show that interaction of the viral Env protein with the virus entry receptor Hyal2 is not r

293 Screening on AH927 cells yielded Env proteins with a broader host range, with maximal tit

294 d the disulfide bond profiles of two soluble Env proteins with different designs that are being asses

295 Libraries of FeLV Env proteins with random amino acid substitutions in the

296 Here we show that JSRV and ENTV Env proteins with tyrosine or methionine mutations in th

297 The ability to isolate Env proteins with unique tropisms dependent on the cells

298 eld, showing an abundance of oligomannose on Env protein, with 40 to 50% of glycans being Man(5) to M

299 ccinia Ankara (MVA)-vectored Env and subunit Env protein, with or without a single intravenous coadmi

300 antibodies was highest against HIV-1 clade C Env proteins, with considerable cross-reactivity to othe